Influence of interleukin 1α (IL-1α), IL-4, and IL-6 polymorphisms on genetic susceptibility to chronic osteomyelitis

Clinical and Vaccine Immunology

Volumn 15, Issue 12, 2008, Pages 1888-1890

  Tsezou, Aspasia ^a,b   Poultsides, Lazaros ^a   Kostopoulou, Fotini ^a   Zintzaras, Elias ^a   Satra, Maria ^a   Kitsiou Tzeli, Sofia ^c   Malizos, Konstantinos N ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6;

ARTICLE; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; ADULT; AGED; ALLELE; CHRONIC DISEASE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; OSTEOMYELITIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHRONIC DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-4; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOMYELITIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 57349140347     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00209-08     Document Type: Article

References (17)

1. Asensi, V., E. Valle, A. Meana, J. Fierer, A. Celada, V. Alvarez, J. Paz, E. Coto, J. A. Carton, J. A. Maradona, A. Dieguez, J. Sarasúa, M. G. Ocaña, and J. M. Arribas. 2004. In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis. Infect. Immun. 72:3823-3828.
2. Asensi, V., V. Alvarez, E. Valle, A. Meana, J. Fierer, E. Coto, J. A. Carton, J. A. Maradona, J. Paz, M. A. Dieguez, B. de la Fuente, A. Moreno, S. Rubio, M. J. Tuya, J. Sarasua, S. Llames, and J. M. Arribas. 2003. IL-1α (-889) promoter polymorphism is a risk factor for osteomyelitis. Am. J. Med. Gen. 119A:132-136.
3. Balto, K., H. Sasaki, and P. Stashenko. 2001. Interleukin-6 deficiency increases inflammatory bone destruction. Infect. Immun. 69:744-750.
4. Evans, C. A. W., J. Jellis, S. P. F. Hughes, D. G. Remick, and J. S. Friedland. 1998. Tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis. J. Infect. Dis. 177:1582-1587.
5. Gauderman, W. J., S. Macgregor, L. Briollais, K. Scurrah, M. Tobin, T. Park, D. Wang, S. Rao, S. John, and S. Bull. 2003. Longitudinal data analysis in pedigree studies. Genet. Epidemiol. 25(Suppl. 1):S18-S28.
6. Goodman, S. B., P. Huie, Y. Song, D. Schurman, W. Maloney, S. Woolson, and R. Sibley. 1998. Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J. Bone Jt. Surg. Br. Vol. 80:531-539.
7. Klosterhalfen, B., M. Peters, C. Tons, S. Hauptmann, C. L. Klein, and C. J. Kirkpatrick. 1996. Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. J. Trauma 40:372-378.
8. Knight, J. 2001. Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome. Curr. Infect. Dis. Rep. 3:427-439.
9. Kobayashi, K., N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, T. Morinaga, K. Higashio, T. J. Martin, and T. Suda. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the OD/RANKL-RANK interaction. J. Exp. Med. 191:275-286.
10. Kwan, T. S., M. Padrines, S. Theoleyrre, D. Heymann, and Y. Fortune. 2004. IL-6, RANKL, TNF alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15:49-60.
11. Lew, D. P., and F. A. Waldvogel. 1997. Osteomyelitis. N. Engl. J. Med. 336:999-1007.
12. Manolagas, S. C. 1995. Role of cytokines in bone resorption. Bone 17(Suppl. 2):63S-67S.
13. Miossec, P., P. Chomarat, J. Dechanet, J. F. Moreau, J. P. Roux, P. Delmas, and J. Banchereau. 1994. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum. 37:1715-1722.
14. Pesanti, E. L., and J. A. Lorenzo. 1998. Osteoclasts and effects of interleukin 4 in development of chronic osteomyelitis. Clin. Orthop. Relat. Res. 355:290-299.
15. Song, Z., V. Casolaro, R. Chen, S. N. Georas, D. Monos, and S. J. Ono. 1996. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J. Immunol. 156:424-429.
16. Waldvogel, F. A., G. Medoff, and M. N. Swartz. 1970. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects: osteomyelitis associated with vascular insufficiency. N. Engl. J. Med. 282:316-322.
17. Zintzaras, E., and J. Lau. 2008. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approach. J. Clin. Epidemiol. [Epub ahead of print.] doi:10.1016/j.jcliepi.2007.12.011.